Replies to post #217729 on Biotech Values

[semi_infinite]

Thx. I saw the JV with Genentech. The note made it sound like CRVS was directly involved with MRK the source being MRK's powerpoint.

[jbog]

The best I can find is that Merck acquired Preladenant through the Schering-Plough acquisition.

[DewDiligence]

CRVS sells 8.12M* shares @8.50—an 11% discount to yesterday’s close:

https://finance.yahoo.com/news/corvus-pharmaceuticals-announces-pricing-public-140442703.html

*Assuming exercise of underwriter’s option.